Nicotine-replacement therapy, as a surrogate of smoking, and the risk of hospitalization with Covid-19 and all-cause mortality: a nationwide, observational cohort study in France
Mahmoud Zureik, Bérangère Baricault, Clémentine Vabre, Laura Semenzato, Jérôme Drouin, François Cuenot, Laetitia Penso, Philippe Herlemont, Emilie Sbidian, Alain Weill, Mathieu Molimard, Rosermary Dray-Spira, Jérémie Botton
doi: https://doi.org/10.1101/2020.07.28.20160630
Mahmoud Zureik
1EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
4University Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Anti-infective evasion and pharmacoepidemiology, CESP, 78180, Montigny le Bretonneux, France
M.D., Ph.D.Bérangère Baricault
1EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
Clémentine Vabre
1EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
Pharm.DLaura Semenzato
1EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
Jérôme Drouin
1EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
François Cuenot
1EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
Ph.D.Laetitia Penso
1EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
Philippe Herlemont
1EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
Emilie Sbidian
1EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
2University Paris-Est Créteil, Research Unit Epidemiology in dermatology and evaluation of therapeutics
M.D., Ph.DAlain Weill
1EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
M.D.Mathieu Molimard
3Service of medical pharmacology, university of Bordeaux, Inserm, UMR 1219, Bordeaux population health research center
M.D., Ph.DRosermary Dray-Spira
1EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
M.D., Ph.DJérémie Botton
1EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
Ph.D.Data Availability
According to data protection and the French regulation, the authors can not publicly release the data from the SNDS. However, any person or structure, public or private, for-profit or non-profit, is able to access SNDS data upon authorization from the CNIL, in order to carry out a study, a research or an evaluation of public interest (https://www.snds.gouv.fr)
Posted July 30, 2020.
Nicotine-replacement therapy, as a surrogate of smoking, and the risk of hospitalization with Covid-19 and all-cause mortality: a nationwide, observational cohort study in France
Mahmoud Zureik, Bérangère Baricault, Clémentine Vabre, Laura Semenzato, Jérôme Drouin, François Cuenot, Laetitia Penso, Philippe Herlemont, Emilie Sbidian, Alain Weill, Mathieu Molimard, Rosermary Dray-Spira, Jérémie Botton
medRxiv 2020.07.28.20160630; doi: https://doi.org/10.1101/2020.07.28.20160630
Nicotine-replacement therapy, as a surrogate of smoking, and the risk of hospitalization with Covid-19 and all-cause mortality: a nationwide, observational cohort study in France
Mahmoud Zureik, Bérangère Baricault, Clémentine Vabre, Laura Semenzato, Jérôme Drouin, François Cuenot, Laetitia Penso, Philippe Herlemont, Emilie Sbidian, Alain Weill, Mathieu Molimard, Rosermary Dray-Spira, Jérémie Botton
medRxiv 2020.07.28.20160630; doi: https://doi.org/10.1101/2020.07.28.20160630
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2915)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12707)
- Forensic Medicine (12)
- Gastroenterology (826)
- Genetic and Genomic Medicine (4565)
- Geriatric Medicine (414)
- Health Economics (726)
- Health Informatics (2912)
- Health Policy (1068)
- Hematology (385)
- HIV/AIDS (921)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4329)
- Nursing (234)
- Nutrition (636)
- Oncology (2261)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (497)
- Pediatrics (1196)
- Primary Care Research (494)
- Public and Global Health (6913)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (436)
- Sports Medicine (382)
- Surgery (484)
- Toxicology (60)
- Transplantation (210)
- Urology (178)